China SXT Pharmaceuticals, Inc. (SXTC)

China SXT Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is April - March.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Cash & Equivalents	21.17	18.1	12.07	17.37	15.52	13.33
Short-Term Investments	0.14	0.14	-	-	-	-
Cash & Short-Term Investments	21.31	18.24	12.07	17.37	15.52	13.33
Cash Growth	15.09%	51.09%	-30.50%	11.88%	16.43%	82.97%
Accounts Receivable	1.34	1.3	1.31	1.34	3.37	4.51
Other Receivables	1.43	0.47	0.03	0.23	0.66	0.65
Receivables	2.87	1.9	1.35	1.58	5.53	6.66
Inventory	1.84	1.13	0.81	0.58	1.07	1.38
Restricted Cash	0.03	0.03	0.01	-	0.05	0.03
Other Current Assets	-	-	-	-	0.29	1.83
Total Current Assets	26.04	21.3	14.23	19.52	22.45	23.23
Property, Plant & Equipment	0.3	0.36	0.56	1.27	1.59	1.79
Other Intangible Assets	0.01	0.01	0.02	0.03	0.04	0.05
Long-Term Deferred Tax Assets	-	-	-	-	-	0.32
Other Long-Term Assets	-	-	8.31	8.74	9.46	9.16
Total Assets	26.35	21.66	23.13	29.55	33.55	34.55
Accounts Payable	0.53	1.16	1.28	1.38	1.48	1.46
Accrued Expenses	2.08	1.78	1.59	1.74	2.01	1.51
Short-Term Debt	0.98	0.7	3.32	8.53	10.73	12.15
Current Portion of Long-Term Debt	0	0.01	0.02	0.01	0.01	0.04
Current Portion of Leases	0.06	0.06	0.06	0.06	-	-
Current Income Taxes Payable	1.04	1.03	1.05	1.1	1.17	1.16
Current Unearned Revenue	0.07	0.06	0.19	0.17	-	-
Other Current Liabilities	1.2	1.21	1.39	1.52	1.72	2.26
Total Current Liabilities	5.96	6.01	8.9	14.5	17.12	18.58
Long-Term Debt	0.07	0.1	0.12	0.12	-	0.01
Long-Term Leases	0.09	0.12	0.18	0.25	-	-
Total Liabilities	6.12	6.22	9.2	14.86	17.12	18.59
Common Stock	55.38	44.53	39.67	0.91	0.16	0.06
Additional Paid-In Capital	-	-	-	35.59	30.99	25.32
Retained Earnings	-34.38	-28.02	-24.71	-21.61	-15.69	-9.95
Comprehensive Income & Other	-0.77	-1.08	-1.03	-0.2	0.96	0.53
Shareholders' Equity	20.23	15.44	13.93	14.69	16.42	15.96
Total Liabilities & Equity	26.35	21.66	23.13	29.55	33.55	34.55
Total Debt	1.2	0.98	3.7	8.96	10.74	12.19
Net Cash (Debt)	20.1	17.25	8.38	8.41	4.78	1.14
Net Cash Growth	132.67%	106.00%	-0.39%	75.82%	319.07%	102.64%
Net Cash Per Share	0.34	12.12	77.24	251.95	-	-
Filing Date Shares Outstanding	116.03	116.03	0.43	0.07	0.01	-
Total Common Shares Outstanding	116.03	13.76	0.28	0.06	0.01	-
Working Capital	20.08	15.28	5.33	5.02	5.33	4.65
Book Value Per Share	0.17	1.12	50.24	256.97	1617.08	-
Tangible Book Value	20.23	15.43	13.91	14.66	16.39	15.92
Tangible Book Value Per Share	0.17	1.12	50.17	256.48	1613.27	-
Machinery	1.06	1.04	1.19	1.24	1.27	1.19
Construction In Progress	-	-	-	-	0.36	0.36
Leasehold Improvements	1.59	1.56	1.56	1.64	1.78	1.7

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q